NKX3-1 has been reported as a tumor suppressor whose functions are closely linked to its mRNA m6A modification status, and loss of NKX3-1 contributed to prostate carcinogenesis and tumor progression [76–78]. The gene discussed is NKX3-1; the disease is medical procedure.